Pretransplant <i>FLT3</i>-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome
Sun Loo(The Royal Melbourne Hospital), Andrew H. Wei(The University of Melbourne), Adam Ivey(The Alfred Hospital), Sean Johnson(Cardiff University), Ashish Bajel(The Royal Melbourne Hospital), Amanda Gilkes(Cardiff University), Ing Soo Tiong(Peter MacCallum Cancer Centre), Manohursingh Runglall(King's College London), Nigel H. Russell(Nottingham University Hospitals NHS Trust), Jad Othman(King's College London), Zhi Han Yeoh(The Royal Melbourne Hospital), Natasha S. Anstee(Walter and Eliza Hall Institute of Medical Research), Ian Thomas(Cardiff University), David Ritchie(Peter MacCallum Cancer Centre), Nicola Potter(European Bioinformatics Institute), Chyn Chua Chong(Walter and Eliza Hall Institute of Medical Research), Michelle McBean(Peter MacCallum Cancer Centre), Richard Dillon(King's College London), Kelli Gray(The Royal Melbourne Hospital), Jelena Jovanović(Centre de Recherche Jean Pierre Aubert)
Cited by 83
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k